Aehr Test Systems stock
AEHRNASDAQTechnologyISIN US00760J1088
40Score 40 out of 100, Weak
Price and trend
58 / 100
Price history
+184% in one yearThe chart shows daily closes over 20 years, adjusted for stock splits and without dividends. Click into the chart to set a price alert at that price.
Below the 200-day line: the price is 13% below it.
Since July 2025 the 50-day line has been above the 200-day line; the trend has turned up.
Normal: the price is neither overheated nor sold off (RSI 57).
The price is 55% below its 52-week high. Largest decline in 20 years: 98% (June 2007 to November 2011).
Chart figures for advanced users
- SMA 50$78.73
- Average price of the last 50 trading days, shows the short-term trend.
- SMA 200$75.60
- Average price of the last 200 trading days, shows the long-term trend.
- RSI (14)57
- Relative strength over the last 14 days on a scale from 0 to 100. Above 70 the price counts as overheated, below 30 as sharply fallen.
- MACDabove the signal line
- Compares a fast and a slow price average. Above its signal line momentum is rising, below it momentum is fading.
- Support$19.40
- The lowest closing price of the last twelve months.
- Resistance$145.61
- The highest closing price of the last twelve months.
Snapshot
Computed from the data by fixed rules, no AI
- Aehr Test Systems belongs to the Semiconductors industry (United States) and, with a market value of $2.15B, is number 162 of 185 companies in its industry on MEQIRI.
- In fiscal 2026 it reported revenue of $50M (down 15.2% year on year) and a loss of $7.13M.
- For fiscal 2027, analysts expect on average revenue of $135.17M (up 170.3%) and adjusted earnings per share of $0.76 (up 2,426.7%).
Show more
- MEQIRI Score 40 out of 100 (Weak): rank 751 of 857 in Technology, median 61.
- The P/E is 1,003.1 (Semiconductors median 38.9, own median of recent years 43.4).
In plain words
The numbers on this page in plain words, written by an AI
Strengths
- Growing faster than its industryRevenue up 24.7% a year since 2021, Semiconductors median 9.1%.Growth 70
- More cash than debtCash $116.36M, financial debt $9.88M.Stability 69
Weaknesses
- Richly valuedP/E 1,003.1, Semiconductors median 38.9, own median 43.4.Valuation 10
- Margin fallingOperating margin −28.3%, average of the prior years 15.2% (to 2025).Profitability 28
- DilutionShare count up 31% since 2021.Capital allocation 18
Its standout strength is growth, while fundamentals and valuation hold the score back.
Daily figure as of 12 Nov 2026
How the score is calculatedScore overview
Fundamental quality fluctuates.
Score history
The full history of up to 20 years comes with MEQIRI Pro.
See plansCrash risk high
How well MEQIRI warnsOne of the 30% with the highest crash risk among smaller stocks.
From 2016 to 2025, 36 in 100 such stocks fell 30% or more within a year, against a group average of 23 in 100.
What drives the risk
- weak fundamentals
- price up very strongly over the past year
- high price swings
Valuation
Valuation signal
OvervaluedA fair value is not meaningful here, so the signal follows the valuation grade.
Valuation metrics
The model puts the fair value at less than a quarter of the share price. That says more about the assumptions than about the company, so a fair value is not meaningful here and the valuation relies on the P/E and the other metrics.
Calculate with your own assumptionsCompany performance
This shows several years of history with an automatic assessment.
Revenue
In fiscal 2026, revenue fell 15.2% on the prior year. Revenue has grown solidly since 2007, at about 3% per year.
Margins
- Gross margin
- Operating margin
- Net margin
In fiscal 2026: gross 35%, operating −28%, net −14%. Last 12 months: net 3%.
Debt & balance sheet
latest quarterDebt is low; no interest coverage is reported.
Earnings
- Next earnings
- 14 Jan 2027in 63 days
- Last reported
- 2 Nov 2026EPS reported $0.28 (expected $0.12)above expectations
Analyst estimates
- Earnings per share
- $0.760.0%
- Revenue
- $135.17M0.0%
- Earnings per share
- $0.94+28.5%
- Revenue
- $148.24M+9.1%
MEQIRI has stored the estimates since 15 Oct 2026. Until 30 days are available, the card shows the change since that day. Mean estimate according to Financial Modeling Prep. No price target and no recommendation.
Company outlook confirmed
Share price after the results: +29.1%First guidance for fiscal 2027: revenue of $130 million to $150 million (2.6x to 3x fiscal 2026), non-GAAP pretax profitability of 18% to 22%, with room to raise as more orders materialize.
“With strong momentum and a record backlog heading into fiscal 2027, we are expecting revenue of between $130 million and $150 million representing 2.6x to 3x the just-completed fiscal 26 revenue. Non GAAP pretax profitability at these levels is expected to come in between 18% to 22%.”The outlook is not part of the score and not a recommendation to buy or sell.
From the earnings call on 14 Jul 2026 (fiscal Q4 2026), read by AI.
Insiders
Open-market purchases and sales by executives, board members and major holders
No open-market purchases in the last 6 months. 10 insiders sold, $19.88M in total.
Sales say less than purchases: many insiders sell on a fixed plan, for taxes or to diversify.
- Rogers VernonSale
17 Aug 2026, Exec VP of Sales & Mktg.
- Shares
- 3,994
- Price
- $143.77
- Value
- $574,217
- Rogers VernonSale
14 Aug 2026, Exec VP of Sales & Mktg.
- Shares
- 2,000
- Price
- $136.50
- Value
- $273,000
- Slayen Howard TSale
14 Aug 2026, Board
- Shares
- 5,700
- Price
- $133.03
- Value
- $758,264
Show 13 more
- Posedel Rhea JSale
14 Aug 2026, Board
- Shares
- 5,973
- Price
- $140.00
- Value
- $836,220
- Salamone AlbertoSale
13 Aug 2026, EVP, PPBI BUSINESS
- Shares
- 9,672
- Price
- $127.72
- Value
- $1.24M
- Erickson GaynSale
12 Aug 2026, President and CEO
- Shares
- 40,000
- Price
- $130.84
- Value
- $5.23M
- Posedel Rhea JSale
12 Aug 2026, Board
- Shares
- 8,413
- Price
- $130.00
- Value
- $1.09M
- Scott Geoffrey GatesSale
12 Aug 2026, Board
- Shares
- 20,000
- Price
- $131.51
- Value
- $2.63M
- Engineer AdilSale
12 Aug 2026, Chief Operating Officer
- Shares
- 15,000
- Price
- $131.02
- Value
- $1.97M
- Oliphant LauraSale
12 Aug 2026, Board
- Shares
- 1,717
- Price
- $133.00
- Value
- $228,361
- Sporck Alistair NSale
10 Aug 2026, VP Contactor Business Unit
- Shares
- 1,000
- Price
- $108.49
- Value
- $108,490
- Sporck Alistair NSale
4 Aug 2026, VP Contactor Business Unit
- Shares
- 2,000
- Price
- $100.96
- Value
- $201,917
- Slayen Howard TSale
4 Aug 2026, Board
- Shares
- 20,000
- Price
- $108.30
- Value
- $2.17M
- Scott Geoffrey GatesSale
16 Jul 2026, Board
- Shares
- 20,000
- Price
- $82.13
- Value
- $1.64M
- Siu ChrisSale
14 May 2026, CFO
- Shares
- 2,070
- Price
- $107.06
- Value
- $221,608
- Slayen Howard TSale
13 May 2026, Board
- Shares
- 6,819
- Price
- $104.73
- Value
- $714,154
Partial trades from one filing are shown in one row, with the average price.
Source: Form 4 filings with the US Securities and Exchange Commission. Grants, option exercises, gifts and tax withholdings are hidden. Not a recommendation to buy.
What happened at Aehr Test Systems
The key events of the last six months from our own data. A click takes you to the matching card.
Sector comparison
857 rated companies in Technology
- This company
- 40
- Sector median
- 61
Categories against the sector median
The median is the middle value: half of the companies in the sector lie above it, half below. Categories with too few comparable companies are left out.
Competitors in Semiconductors
The next larger and next smaller companies by market value
- SiltronicWAF.DE $2.42B35
- Ultra Clean HoldingsUCTT $2.38B38
- Elmos SemiconductorELG.DE $2.2B74
- CohuCOHU $2.18B40
- ams-OSRAMAMS.SW $2.04B40
- ChipMOS TECHNOLOGIESIMOS $1.85B58
- PhotronicsPLAB $1.71B71
- Himax TechnologiesHIMX $1.59B46
ETFs that hold Aehr Test Systems
Held by 12 ETFs on Xetra. Shown per index: the ETF with the largest weight.
| ETF | Weight | Cost | Fund size |
|---|---|---|---|
| iShares Automation & Robotics UCITS ETF2B76 | 0.09% | 0.40% | €4.49B |
| Xtrackers Russell 2000 UCITS ETF 1CXRS2 | 0.06% | 0.30% | €2.17B |
| State Street SPDR Russell 2000 U.S. Small Cap UCITS ETF (Acc)ZPRR | 0.06% | 0.30% | €4.22B |
Show 5 more
| L&G Russell 2000 US Small Cap Quality UCITS ETFETLZ | 0.03% | 0.30% | €185.82M |
| iShares MSCI USA Small Cap CTB Enhanced ESG UCITS ETFSXRG | 0.02% | 0.43% | €2.48B |
| State Street SPDR MSCI World Small Cap UCITS ETF (Acc)ZPRS | 0.02% | 0.45% | €1.53B |
| iShares MSCI World Small Cap CTB Enhanced ESG UCITS ETFCBUG | 0.01% | 0.35% | €434.1M |
| UBS MSCI USA Select Factor Mix UCITS ETF USD accUSUE | 0.01% | 0.25% | €175.89M |
Holdings as reported by the funds via FMP, excluding swap ETFs (their holdings are only collateral).
Data status and sources
- Score
- Daily value of 12 Nov 2026, recalculated nightly
- Price
- Closing price of 11 Nov 2026
- Latest annual report
- Fiscal year 2026, period end 29 May 2026
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Weak, published since 7 Nov 2026 (in the score history since 9 Oct 2026)
- Valuation signal Overvalued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.